Details

Autor(en) / Beteiligte

• Nguyen, Minh Thu
• Goldblatt, Jack
• Isasi, Rosario
• Jagut, Marlene
• Jonker, Anneliene Hechtelt
• Kaufmann, Petra
• Ouillade, Laetitia
• Molnar-Gabor, Fruszina
• Shabani, Mahsa
• Sid, Eric
• Tassé, Anne Marie
• Wong-Rieger, Durhane
• Knoppers, Bartha Maria

Titel

Model consent clauses for rare disease research

Ist Teil von

• BMC medical ethics, 2019-08, Vol.20 (1), p.55-55, Article 55

Ort / Verlag

England: BioMed Central Ltd

Erscheinungsjahr

2019

Quelle

Elektronische Zeitschriftenbibliothek - Freely accessible e-journals

Beschreibungen/Notizen

• Rare Disease research has seen tremendous advancements over the last decades, with the development of new technologies, various global collaborative efforts and improved data sharing. To maximize the impact of and to further build on these developments, there is a need for model consent clauses for rare diseases research, in order to improve data interoperability, to meet the informational needs of participants, and to ensure proper ethical and legal use of data sources and participants' overall protection. A global Task Force was set up to develop model consent clauses specific to rare diseases research, that are comprehensive, harmonized, readily accessible, and internationally applicable, facilitating the recruitment and consent of rare disease research participants around the world. Existing consent forms and notices of consent were analyzed and classified under different consent themes, which were used as background to develop the model consent clauses. The IRDiRC-GA4GH MCC Task Force met in September 2018, to discuss and design model consent clauses. Based on analyzed consent forms, they listed generic core elements and designed the following rare disease research specific core elements; Rare Disease Research Introductory Clause, Familial Participation, Audio/Visual Imaging, Collecting, storing, sharing of rare disease data, Recontact for matching, Data Linkage, Return of Results to Family Members, Incapacity/Death, and Benefits. The model consent clauses presented in this article have been drafted to highlight consent elements that bear in mind the trends in rare disease research, while providing a tool to help foster harmonization and collaborative efforts.